Clinical Trial

Membrane Potential Mapping with18F-TPP

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
In this study, investigators propose to use PET imaging to study the pharmacokinetics of 18F-TPP and develop methods for imaging membrane potential (ΔΨT) in humans.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-26.
Trial Details
NCT Number NCT07506616
Lead Sponsor Yale University
Collaborators: National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Conditions Membrane Potential Mapping
Enrollment 24 participants
Start Date 2026-06
Primary Completion 2033-08 (estimated)
Study Completion 2033-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-15